Literature DB >> 3777630

Barbiturate anesthesia in greyhound and mixed-breed dogs: comparative cardiopulmonary effects, anesthetic effects, and recovery rates.

E P Robinson, R A Sams, W W Muir.   

Abstract

The cardiovascular effects, anesthetic effects, and recovery rates were evaluated in racing Greyhounds under barbiturate anesthesia. Greyhounds and mixed-breed dogs of similar body weights were given (by IV route) thiopental (15 mg/kg), thiamylal (15 mg/kg), methohexital (10 mg/kg), and pentobarbital (20 mg/kg). The anesthesia lasted longer in Greyhound than in non-Greyhound mixed-breed dogs given thiopental, thiamylal, and methohexital. The mean times from recumbency to standing were 3 to 4 times longer for Greyhounds anesthetized with thiobarbiturates than for non-Greyhound mixed-breed dogs anesthetized with the same drugs, with recovery times for some Greyhounds lasting more than 8 hours. With thiobarbiturate anesthesia, Greyhounds had long periods of respiratory depression, struggled, and relapsed into sleep, whereas in the other dogs, the recovery was quiet. Respiratory depression related to the stage of anesthesia was produced by all barbiturates, but did not result in significant changes in blood gas values. Rectal temperature decreased in all dogs, but did not result in significant hypothermia. Cardiovascular variables and acid-base estimations in Greyhounds were not significantly different from those in mixed-breed dogs before and during barbiturate anesthesia. Packed cell volumes in Greyhounds were significantly higher than those in non-Greyhound mixed-breed dogs after the thiobarbiturates and methohexital were administered. Total plasma protein concentrations were significantly lower in Greyhounds, compared with those in the other dogs before and during barbiturate anesthesia. Methohexital is a useful alternative to thiobarbiturates for short-duration barbiturate anesthesia in Greyhounds.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3777630

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

Review 1.  Factors influencing the bioavailability of peroral formulations of drugs for dogs.

Authors:  S Sabnis
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

2.  Effects of age and breed on the phospholipid composition of canine surfactant.

Authors:  C Clercx; A J Venker-van Haagen; J N den Breejen; H P Haagsman; W E van den Brom; H W de Vries; L M van Golde
Journal:  Lung       Date:  1989       Impact factor: 2.584

Review 3.  Clinical pharmacokinetics in veterinary medicine.

Authors:  J D Baggot
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

4.  Comparison of direct and indirect blood pressure measurements in anesthetized dogs.

Authors:  M J Gains; K M Grodecki; R M Jacobs; D Dyson; R A Foster
Journal:  Can J Vet Res       Date:  1995-07       Impact factor: 1.310

Review 5.  Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model.

Authors:  Steven Fleischer; Michele Sharkey; Katrina Mealey; Elaine A Ostrander; Marilyn Martinez
Journal:  AAPS J       Date:  2008-02-15       Impact factor: 4.009

6.  Canine cytochrome P-450 pharmacogenetics.

Authors:  Michael H Court
Journal:  Vet Clin North Am Small Anim Pract       Date:  2013-06-13       Impact factor: 2.093

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.